EFFECT OF REMIBRUTINIB ON SLEEP AND DAILY ACTIVITIES IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA (CSU) UP TO WEEK 52 IN THE REMIX-1/-2 STUDIES